Benjamin List

Benjamin List
Born	Benjamin List 1/11/1968
Birthplace	Frankfurt, West Germany
Nationality	German
Occupation	Chemist, academic
Employer	Max Planck Institute for Coal Research, University of Cologne
Known for	Development of asymmetric organocatalysis
Education	Goethe University Frankfurt (PhD)
Awards	Gottfried Wilhelm Leibniz Prize (2016), Nobel Prize in Chemistry (2021)

Benjamin List (born 11 January 1968) is a German chemist who fundamentally changed how chemists think about catalysis. His work on organocatalysis—using small organic molecules to speed up chemical reactions—reshaped asymmetric synthesis and earned him the 2021 Nobel Prize in Chemistry. Together with Scottish-American chemist David MacMillan, List was recognized by the Royal Swedish Academy of Sciences "for the development of asymmetric organocatalysis," a method that gave chemists a precise and environmentally friendlier way to build molecules.

List directs the Max Planck Institute for Coal Research (Max-Planck-Institut für Kohlenforschung) in Mülheim an der Ruhr, Germany, and teaches organic chemistry at the University of Cologne. His aunt is developmental biologist Christiane Nüsslein-Volhard, who won the Nobel Prize in Physiology or Medicine in 1995. That makes the List-Nüsslein-Volhard family one of the rare households with two Nobel laureates among close relatives.

Over more than two decades, List's published work has continued pushing organocatalysis forward. His group's recent contributions span catalytic asymmetric fragmentation, cyclopropanation, and ways to transform biomass-derived chemicals into useful products.

Early Life

Benjamin List was born on 11 January 1968 in Frankfurt, then part of West Germany. He grew up surrounded by science. His aunt, Christiane Nüsslein-Volhard, is a distinguished developmental biologist who won the Nobel Prize in Physiology or Medicine in 1995 for her discoveries about genetic control of early embryonic development. This family connection to serious scientific work created an environment where intellectual curiosity was prized, though List has spoken about charting his own path in the natural sciences.

Chemistry drew him in as a discipline that offered a singular way of looking at life and the natural world. He's reflected on the meaning of scientific inquiry and stressed the need for broad human diversity within science. His early fascination with chemistry naturally led him to Germany's top universities.

Education

List earned his Diplom (the German equivalent of a master's degree) in chemistry from the Free University of Berlin. He then moved to Goethe University Frankfurt for doctoral work. Working under organic chemist Johann Mulzer, List finished his PhD in 1997. His thesis covered Synthese eines Vitamin B₁₂ Semicorrins (Synthesis of a Vitamin B₁₂ Semicorrin). This doctoral research focused on total synthesis of complex natural product fragments, giving List a solid grounding in synthetic organic chemistry.

After his doctorate, he moved to The Scripps Research Institute in La Jolla, California, for postdoctoral work under Richard Lerner and Carlos F. Barbas III, both leaders in chemical biology and catalytic antibodies. This was where List began investigating amino acid-catalyzed reactions. Those investigations would eventually lead to his transformative organocatalysis work.

Career

Early Research and the Discovery of Proline Catalysis

List started by asking a simple question that had never received a clear answer: could individual amino acids, those building blocks of enzymes, act as catalysts on their own? Enzymes are large, complicated proteins with exceptional catalytic power. Metal-based catalysts had dominated asymmetric synthesis in labs and industry. Before List, nobody'd seriously explored whether small, simple organic molecules could serve as effective asymmetric catalysts, and it wasn't viewed as a general principle.

In 2000, early in his independent research career, List published a landmark paper. It showed that proline—one amino acid—could catalyze an aldol reaction, a fundamental carbon-carbon bond-forming reaction, with remarkable selectivity. Proline is small and cheap. It drove the formation of one mirror image form (enantiomer) of a product over the other, something once thought possible only with metal catalysts or enzymes. This established organocatalysis as a viable and general strategy for asymmetric synthesis, standing alongside metal catalysis and biocatalysis as a third pillar of the field.

Around the same time, David MacMillan at the University of California, Berkeley, reported that small organic amines could catalyze Diels-Alder reactions. MacMillan coined the term "organocatalysis." These parallel discoveries opened an entirely new research space, and the two scientists shared the 2021 Nobel Prize in Chemistry.

Max Planck Institute for Coal Research

In 2003, List became a director at the Max Planck Institute for Coal Research (Max-Planck-Institut für Kohlenforschung) in Mülheim an der Ruhr, one of Germany's oldest and most respected chemical research institutions. Founded in 1912, the institute had built its reputation in catalysis, counting Karl Ziegler and Gerhard Ertl among its affiliated Nobel laureates. List's appointment placed him in this tradition. He founded the Department of Homogeneous Catalysis, where his research group developed new organocatalytic methods and deepened mechanistic understanding of the field.

His research group explored a wide range of organocatalytic activation modes. Building on proline-catalyzed reactions, they investigated enamine catalysis, iminium catalysis, Brønsted acid catalysis, and other strategies. One significant line of work involved confined Brønsted acid catalysts. These are strong chiral acids whose catalytic sites sit enclosed within a molecular pocket, allowing exceptional stereochemical control. Based on imidodiphosphorimidate frameworks, they enabled reactions previously considered extremely difficult or impossible to do in an enantioselective way.

List also developed asymmetric counteranion-directed catalysis (ACDC), where a chiral counteranion paired with a reactive cation intermediate controls stereochemical outcome. This proved broadly useful, extending organocatalysis beyond traditional covalent activation. His group continues applying this concept. A 2025 report in Nature Catalysis described an organocatalytic enantioselective cyclopropanation of olefins using diazoalkanes and asymmetric counteranion-directed catalysis, offering a metal-free option to established cyclopropanation methods.

Expanding the Scope of Organocatalysis

Throughout the 2010s and into the 2020s, List's research group kept pushing what organocatalysis could do. They focused on activating substrates that normally don't react easily. October 2024 brought a Science publication on catalytic asymmetric fragmentation of cyclopropanes, tackling the long-standing challenge of stereoselective alkane activation—a fundamental problem in organic chemistry.

Another active area involves applying organocatalysis to sustainability. A 2025 Science publication on the photohydrolysis of furans tackled converting biomass-derived feedstocks into useful chemicals—a key step in moving the chemical industry away from petroleum. That work shows how organocatalysis tools can address sustainability, including replacing petroleum-based raw materials with renewable biomass-based alternatives.

April 2025 saw a Nature Communications publication on bis-indole chiral architectures for asymmetric catalysis. His team reported new privileged chiral scaffolds that may enable more effective asymmetric transformations. Developing new catalyst scaffolds remains core to his research program.

Academic Positions and International Engagement

Beyond his directorship at the Max Planck Institute for Coal Research, List holds a professorship of organic chemistry at the University of Cologne. He's also worked with Hokkaido University in Japan, contributing to the Institute for Chemical Reaction Design and Discovery (ICReDD). His involvement with ICReDD reflects interest in combining computational and experimental approaches to reaction design—a growing frontier in modern chemistry.

He's also received a European Research Council (ERC) Advanced Grant, which provided significant funding for his organocatalysis research.

Personal Life

Christiane Nüsslein-Volhard, Benjamin List's aunt, is a Nobel laureate in Physiology or Medicine (1995). This makes their family one of a small number worldwide with multiple Nobel Prize winners among close relatives. In interviews, List has emphasized the importance of diversity in science and the need for the scientific community to reflect the full range of human backgrounds and perspectives. He lives in Germany, where he continues his research and teaching.

Recognition

Nobel Prize in Chemistry (2021)

On 6 October 2021, the Royal Swedish Academy of Sciences announced that Benjamin List and David MacMillan had won the Nobel Prize in Chemistry "for the development of asymmetric organocatalysis." The Nobel Committee described their work as transformative, noting that organocatalysis gave chemists a new, precise tool for molecular construction. They highlighted that organocatalytic methods are often simpler, cheaper, and more environmentally friendly than traditional metal-based catalytic approaches, with uses ranging from pharmaceutical synthesis to fine chemicals production.

The prize brought international attention to organocatalysis and to the broader idea that simple organic molecules could match metals and enzymes as catalysts for complex transformations. The Max Planck Society's profile of List characterized the award as recognition of both fundamental discovery and the practical impact organocatalysis has had across chemistry.

Gottfried Wilhelm Leibniz Prize (2016)

List received the Gottfried Wilhelm Leibniz Prize in 2016, Germany's most prestigious research award, administered by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG). The Leibniz Prize honors outstanding researchers working in Germany and provides substantial funding. His receipt reflected the weight of his contributions to catalysis and organic chemistry.

Other Awards and Honors

List has collected numerous awards and honors from scientific organizations worldwide throughout his career. He's delivered named lectures at leading universities, including the Herbert C. Brown Lectures in Organic Chemistry at Purdue University in 2019. The European Research Council recognized him with an ERC Advanced Grant, providing major funding for his ongoing research.

Legacy

List's development of asymmetric organocatalysis, together with MacMillan's independent and complementary work, established a third major catalysis mode alongside metal catalysis and biocatalysis. Before their early-2000s discoveries, asymmetric catalysis relied almost entirely on transition metal complexes or enzymes. By showing that small organic molecules like proline could achieve similar selectivity and efficiency, List and MacMillan opened up a new approach in synthetic chemistry.

The practical impact has been extensive. Small organic molecules are generally cheaper, more stable, and less toxic than many metal-based catalysts, so organocatalytic methods spread quickly through pharmaceutical research, agrochemical synthesis, and materials science. The elimination of trace metal contamination matters for pharmaceuticals and electronic materials. Also, organocatalytic reactions often happen under milder conditions with simpler setups, lowering barriers to synthesizing complex molecules.

His ongoing research at the Max Planck Institute for Coal Research continues expanding organocatalysis into new reaction types and applications, including activating traditionally inert substrates and converting renewable biomass feedstocks into valuable chemicals. His work on confined Brønsted acid catalysts and asymmetric counteranion-directed catalysis introduced new conceptual frameworks now used by research groups worldwide.

As a director at one of the world's leading chemical research institutes and a professor at the University of Cologne, List has trained a generation of young chemists who've established their own research programs. Organocatalysis, which he co-founded, now constitutes a major area of chemical research, with thousands of publications annually and an expanding array of industrial applications.